B Anderegg - Concepedia

Author

B Anderegg

Also Known As

B Anderegg, B. Anderegg, BIRGIT ANDEREGG, Birgit Anderegg

Publications

316

Citations

H-Index

Concepts

All Affiliations

B Anderegg is an author at MerLion Pharma (Germany) specializing in medicine, cell biology, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	193
2	Cell Biology	3	3	107
3	Public Health	1	1	86
4	Biostatistics	1	1	86
5	Obstetrics	1	1	86

B Anderegg

Publications

273

Citations

H-Index

Page 1

	Year	Citations
Analysis of Gene Amplification and Prognostic Markers in Ovarian Cancer Using Comparative Genomic Hybridization for Microarrays and Immunohistochemical Analysis for Tissue Microarrays Doris Mayr, Veronika Kanitz, B Anderegg, American Journal of Clinical Pathology Gene AmplificationPathologyGynecologyGene Expression ProfilingPrognostic Markers	2006	86
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells Tomonari Suzuki, B Anderegg, Toshika Ohkawa, Gene Therapy Tumor BiologyBreast OncologyVivo GrowthMedicineBreast Cancer Cells	2000	58
Does endometriosis really have premalignant potential? A clonal analysis of laser‐microdissected tissue Doris Mayr, Gudrun Amann, Christina Siefert, The FASEB Journal	2003	41
Therapeutic Efficacy of an Adenovirus-Mediated Anti-H- <i>ras</i> Ribozyme in Experimental Bladder Cancer Akira Irie, B Anderegg, Mohammed Kashani–Sabet, Antisense and Nucleic Acid Drug Development	1999	39
Frequent reduction or loss of DCC gene expression in human osteosarcoma MA Horstmann, M Pösl, RB Scholz, British Journal of Cancer OncologyOncogenic AgentFrequent ReductionMedicineDcc Gene Expression	1997	29
Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells Akira Irie, Kazumasa Matsumoto, B Anderegg, Cancer Gene Therapy Cancer-associated VirusMedicineAnti-erbb2 RibozymeCell BiologyCancer Treatment	2005	20

Page 1